Palamaris, K.; Alexandris, D.; Stylianou, K.; Giatras, I.; Stofas, A.; Kaitatzoglou, C.; Migkou, M.; Goutas, D.; Psimenou, E.; Theodoropoulou, E.;
et al. Immune Checkpoint Inhibitors’ Associated Renal Toxicity: A Series of 12 Cases. J. Clin. Med. 2022, 11, 4786.
https://doi.org/10.3390/jcm11164786
AMA Style
Palamaris K, Alexandris D, Stylianou K, Giatras I, Stofas A, Kaitatzoglou C, Migkou M, Goutas D, Psimenou E, Theodoropoulou E,
et al. Immune Checkpoint Inhibitors’ Associated Renal Toxicity: A Series of 12 Cases. Journal of Clinical Medicine. 2022; 11(16):4786.
https://doi.org/10.3390/jcm11164786
Chicago/Turabian Style
Palamaris, Kostas, Dimitrios Alexandris, Kostas Stylianou, Ioannis Giatras, Anastasios Stofas, Christina Kaitatzoglou, Magda Migkou, Dimitrios Goutas, Erasmia Psimenou, Eleni Theodoropoulou,
and et al. 2022. "Immune Checkpoint Inhibitors’ Associated Renal Toxicity: A Series of 12 Cases" Journal of Clinical Medicine 11, no. 16: 4786.
https://doi.org/10.3390/jcm11164786
APA Style
Palamaris, K., Alexandris, D., Stylianou, K., Giatras, I., Stofas, A., Kaitatzoglou, C., Migkou, M., Goutas, D., Psimenou, E., Theodoropoulou, E., Theocharis, S., Alevizopoulos, N., Kastritis, E., Gerakis, A., & Gakiopoulou, H.
(2022). Immune Checkpoint Inhibitors’ Associated Renal Toxicity: A Series of 12 Cases. Journal of Clinical Medicine, 11(16), 4786.
https://doi.org/10.3390/jcm11164786
